杂志简称：cancer cytopathol
中文译名：《癌症细胞病理学》
收录属性：scie（2024版）, 目次收录（维普）, 目次收录（知网）,英文期刊,
自引率：17.70%
投稿方向：医学、pathology病理学、oncology肿瘤学
SCI/E期刊基本信息
出版周期：月刊 地区：美国
中科院分区：2区
是否TOP：非TOP期刊
是否综述：非综述期刊
是否OA：非OA期刊
国际标准刊号：ISSN 1934-662X；EISSN 1934-6638
杂志语言：英语
出版国家：美国
杂志官网 联系方式
出版地址：111 RIVER ST,HOBOKEN,USA,NJ,07030-5774
杂志邮箱：
投稿网址：http://mc.manuscriptcentral.com/cancercyto
杂志官方网址：https://acsjournals.onlinelibrary.wiley.com/journal/19346638
出版商网址：http://www.wiley.com/WileyCDA/
杂志投稿要求
2. AIMS AND SCOPE
Cancer Cytopathology provides a unique forum for interaction and dissemination of original research and educational information relevant to the practice of cytopathology and its related oncologic disciplines. The journal strives to have a positive effect on cancer prevention, early detection, diagnosis, and cure by the publication of high-quality content. The mission of Cancer Cytopathology is to present and inform readers of new applications, technological advances, cutting-edge research, novel applications of molecular techniques, and relevant review articles related to cytopathology.
AMERICAN CANCER SOCIETY MISSION
The American Cancer Society is the nationwide community based voluntary health organization dedicated to eliminating cancer as a major health problem by preventing cancer, saving lives and diminishing suffering from cancer through research, education, advocacy, and service.
3. MANUSCRIPT CATEGORIES AND REQUIREMENTS
Manuscripts must be submitted to Cancer Cytopathology via ScholarOne Manuscripts. Please contact the Cancer Cytopathology Editorial Office at (404) 327-6411 or cancercyto@cancer.org if you have any questions about submitting your manuscript online.
Papers that exceed the length limitations as described in this guide will not be considered for review.
Original Articles: Scientific reports of the results of original clinical research. The text is limited to 6000 words including the title page, abstract, text, references, and tables. Abstracts are limited to 250 words.
Review Articles: A timely, in-depth treatment of an issue. Review articles are generally solicited by the editors, but unsolicited materials will be considered. Review articles must be no longer than 8000 words including title page, abstract, text, tables, and references.
Editorials: Opinions of recognized leaders in oncologic specialties. Editorials are generally solicited by the Editor-in-Chief and are related to a manuscript in the same issue. Length should not exceed 2400 words with no more than 20 references.
Commentaries: Presents a point of view of general interest not related to an article in the same issue of Cancer Cytopathology.
Tributes: Highlights the accomplishments of distinguished individuals for their contributions to oncology.
Correspondence: Letters to the Editor related to papers previously published in Cancer Cytopathology. Letters must be submitted within three months of the online publication date of the article discussed in order to be considered. The authors of the original publication will be given the opportunity to respond in the same issue of Cancer Cytopathology. Letters and responses must not exceed 400 words in length, must be limited to three authors and five references, and should not have tables or figures. Financial associations or other potential conflicts of interest must be disclosed.
Case reports of single cases will not be considered.